Back
Delek US Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
33
DK
Delek US Holdings
Last Price:
24.15
Seasonality Move:
1.95%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Sell
33
Delek US Holdings (DK)
is a Sell
Is Delek US Holdings a Buy, Sell or Hold?
- The current Delek US Holdings [DK] share price is $24.15. The Score for DK is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- DK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DK Stock Price Chart
What is Delek US Holdings's stock price today?
-
The Delek US Holdings share price today is $24.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DK is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
DK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.98 | Sell |
Relative Strength Index (14 RSI): | 33.28 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.15 - 27.29) | Sell |
Bollinger Bands (100): | (25.59 - 30.15) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.73 | Sell |
Relative Strength Index (14 RSI): | 45.77 | Sell |
Chaikin Money Flow: | 722527 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.99 - 42.29) | Sell |
Bollinger Bands (100): | (41.03 - 48.83) | Sell |
DK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.11 | Buy |
20-day SMA: | 25.13 | Sell |
50-day SMA: | 27.26 | Sell |
200-day SMA: | 27.33 | Sell |
8-day EMA: | 24.26 | Sell |
20-day EMA: | 25.11 | Sell |
50-day EMA: | 26.54 | Sell |
200-day EMA: | 27.03 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.38 | Sell |
20-day SMA: | 40.41 | Sell |
50-day SMA: | 41.94 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.76 | Sell |
20-day EMA: | 40.54 | Sell |
50-day EMA: | 42.03 | Sell |
200-day EMA: | 43.46 | Sell |
Delek US Holdings Earnings Growth & DK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.52 per share, a decrease next quarter of $0.33 per share, a decrease this year of $1.98 per share, and an increase next year of $0.19 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Delek US Holdings Technical Analysis
Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |